Literature DB >> 15027487

Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Alberto Mantovani1, Silvano Sozzani, Massimo Locati, Tiziana Schioppa, Alessandra Saccani, Paola Allavena, Antonio Sica.   

Abstract

Macrophages and dendritic cells infiltrate tumours. In the tumour microenvironment, mononuclear phagocytes acquire properties of polarized M2 (or alternatively activated) macrophages. These functionally polarized cells, and similarly oriented or immature dendritic cells present in tumours, play a key role in subversion of adaptive immunity and in inflammatory circuits which promote tumour growth and progression.

Entities:  

Mesh:

Year:  2004        PMID: 15027487

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  26 in total

1.  Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice.

Authors:  Elizabeth F Redente; David J Orlicky; Ronald J Bouchard; Alvin M Malkinson
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 2.  Macrophage diversity in cardiac inflammation: a review.

Authors:  Jobert G Barin; Noel R Rose; Daniela Ciháková
Journal:  Immunobiology       Date:  2011-06-30       Impact factor: 3.144

Review 3.  Macrophages-Key cells in the response to wear debris from joint replacements.

Authors:  Christophe Nich; Yuya Takakubo; Jukka Pajarinen; Mari Ainola; Abdelhakim Salem; Tarvo Sillat; Allison J Rao; Milan Raska; Yasunobu Tamaki; Michiaki Takagi; Yrjö T Konttinen; Stuart B Goodman; Jiri Gallo
Journal:  J Biomed Mater Res A       Date:  2013-04-09       Impact factor: 4.396

Review 4.  Macrophages under pressure: the role of macrophage polarization in hypertension.

Authors:  Sailesh C Harwani
Journal:  Transl Res       Date:  2017-11-08       Impact factor: 7.012

5.  Long-lasting complete response of metastatic melanoma to ipilimumab with analysis of the resident immune cells.

Authors:  Birgit Tsaknakis; Inga-Marie Schaefer; Harald Schwörer; Carsten-Oliver Sahlmann; Kai-Martin Thoms; Martina Blaschke; Giuliano Ramadori; Silke Cameron
Journal:  Med Oncol       Date:  2013-12-14       Impact factor: 3.064

6.  The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.

Authors:  Leslee Sprague; Maria Muccioli; Michelle Pate; Evan Meles; John McGinty; Harika Nandigam; Amritha K Venkatesh; Ming-Yu Gu; Kristen Mansfield; Andrew Rutowski; Omowaleola Omosebi; Maria C Courreges; Fabian Benencia
Journal:  BMC Immunol       Date:  2011-06-06       Impact factor: 3.615

Review 7.  Pattern response of dendritic cells in the tumor microenvironment and breast cancer.

Authors:  Alessandra da Cunha; Marcia A Michelin; Eddie Fc Murta
Journal:  World J Clin Oncol       Date:  2014-08-10

8.  Adhesion to substrates induces dendritic cell endothelization and decreases immunological response.

Authors:  Jacob Osterbur; Leslee Sprague; Maria Muccioli; Michelle Pate; Kristen Mansfield; John McGinty; Yihan Li; Yandi Li; Venktesh Shirure; Maria Cecilia Courreges; Fabian Benencia
Journal:  Immunobiology       Date:  2012-02-27       Impact factor: 3.144

9.  CD8+ tumor-infiltrating T cells are trapped in the tumor-dendritic cell network.

Authors:  Alexandre Boissonnas; Fabrice Licata; Lucie Poupel; Sébastien Jacquelin; Luc Fetler; Sophie Krumeich; Clotilde Théry; Sébastian Amigorena; Christophe Combadière
Journal:  Neoplasia       Date:  2013-01       Impact factor: 5.715

10.  Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment.

Authors:  Jonathan M Weiss; Timothy C Back; Anthony J Scarzello; Jeff J Subleski; Veronica L Hall; Jimmy K Stauffer; Xin Chen; Dejan Micic; Kory Alderson; William J Murphy; Robert H Wiltrout
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.